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milk with leptin antagonist or breast milk with 0.4%NaHCO3, the
solvent of the leptin antagonist, were in SB, SF, SFL, SBLA or SBN
group. Within the 20 days after birth, the pup rats were fed with breast
milk, formula milk, breast milk with leptin antagonist or formula milk
with leptin respectively. After that the normal rat diet was obtained.
The weight (Wt), nose-to-anus length, abdominal girth (AG) and body
mass index (BMI) were measured and the serum leptin, total choles-
terol (TC) and triglyceride (TG) were detected by ELISA at the 18th,
30th, 90th and 120th day of life.
RESULTS Compared with the AB group, the rats in SB group had low
Wt, AG and BMI and high leptin level in all detecting days and high
TC level at the 30th and 90th day but low TC level at the 120th day (all
P<0.05). Compared with the AF group, the rats in SF group had low
development data and high leptin and low TC and TG level at the
18th day and high TC and TG level at 90th and 120th day (all P<0.05).
Compared with SB group, the rats in SF group had high TG level at
90th and 120th day (all P<0.05) but the rats in SFL group had similar
data (all P>0.05). Compared with SBN group, the rats in SB group
had the similar data (all P>0.05) and the rats in SBLA group had low
leptin and high TC and TG level at the 90th and 120th day (all
P<0.05). Compared with SF group, the rats in SFL group had low
BMI and low TC and TG and high leptin level at the 90th and 120th
day (all P<0.05), but the rats in SBLA group had the similar data (all
P>0.05).
CONCLUSIONS Breast feeding at early stage might prevent the
abnormal lipid metabolisms of the female SGA rats during adulthood,
which could be inhibited by the leptin antagonist. After adding
leptin with formula milk, it could imitate the preventive effect of the
breast milk. Our results indicated that the breast milk leptin is the
important factor to prevent lipid metabolic disturbance in adulthood
of SGA rats.GW26-e4734
High prevalence of dyslipidemia and associated risk factors among rural
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OBJECTIVES Dyslipidemia is a key independent modiﬁable risk factor
for Cardiovascular Disease, which is a leading contributor to morbidity
and mortality in most developed and developing countries. This study
was designed to investigate the current epidemiological features of
dyslipidemia among adults in rural China.
METHODS Between January 2013 to August 2013, we conducted a
cross-sectional study involving 11,956 subjects with age  35 years in a
normal Chinese population. Permanent residents of the population
were invited to participate in the study and the response rate was at
85.3%. Dyslipidemia was identiﬁed based on serum lipids levels
following the standards proposed by the National Cholesterol Edu-
cation Program Adult Treatment Panel III. Multivariate logistic
regression analysis was used to evaluate the associated risk factors for
dyslipidemia.
RESULTS Within the study population, 16.4% had high TC, 13.8% had
low HDL-C, 7.6% had high LDL-C, and 17.3% had high TG concentra-
tions. Prevalence of lipid abnormality (including borderline dyslipi-
demia and dyslipidemia) was 47.8%, 13.8%, 25.7% and 30.7% for TC,
HDL-C, LDL-C and TG, respectively. Detailed analysis indicated that
36.9% of this population had at least one type of dyslipidemia and
64.4% had at least one type of abnormal lipid concentration. Thus,
this study observed an alarmingly higher prevalence of lipid abnor-
mality, in a relatively large population, compared to previous studies.
Further, we determined that not all of the risk factors studied,
including age, gender, hypertension, diabetes mellitus, obesity,
smoking, drinking, education level, marital status, and family income,
inﬂuenced dyslipidemia to the same extent.
CONCLUSIONS Our present study, in a population of 11,956 adults in
Liaoning Providence, demonstrated a very high prevalence of dysli-
pidemia, which represented an alarming rise since the publication of
our previous study and other similar studies around the world, which
report lower levels. We also examined various risk factors for dysli-
pidemia, many of which are modiﬁable risk factors for CardiovascularDisease (CVD), to provide a comprehensive view that will help in
designing strategies to slow the rapid spread and promote effective
measures to treat dyslipidemia. Our ultimate goal is to prevent the
increasing prevalence of lipid abnormality and reduce the burden of
CVD in rural China.
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Association of elevated apoA-I glycation and reduced HDL-associated
paraoxonase 1, 3 activity, and their interaction with angiographic severity
of coronary artery disease in patients with type 2 diabetes mellitus
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OBJECTIVES To investigate whether apolipoprotein A (apoA)-I gly-
cation and paraoxonase (PON) activities are associated with the
severity of coronary artery disease (CAD) in patients with type 2 dia-
betes mellitus (T2DM).
METHODS Relative intensity of apoA-I glycation and activities of
high-density lipoprotein (HDL)-associated PON1 and PON3 were
determined in 205 consecutive T2DM patients with stable angina with
(n¼144) or without (n¼61) signiﬁcant CAD (luminal diameter sten-
osis70%). The severity of CAD was expressed by number of diseased
coronary arteries, extent index, and cumulative coronary stenosis
score (CCSS).
RESULTS The relative intensity of apoA-I glycation was higher but
the activities of HDL-associated PON1 and PON3 were lower in
diabetic patients with signiﬁcant CAD than in those without. The
relative intensity of apoA-I glycation increased but the activities
of HDL-associated PON1 and PON3 decreased stepwise from 1- to
3-vessel disease patients (P for trend<0.001). After adjusting for
possible confounding variables, the relative intensity of apoA-I
glycation correlated positively, while the activities of HDL-associ-
ated PON1 and PON3 negatively, with extent index and CCSS,
respectively. At high level of apoA-I glycation (8.70w12.50%), low
tertile of HDL-associated PON1 (7.03w38.97U/mL) and PON3 activ-
ities (7.11w22.30U/mL) was associated with a 1.97- and 2.49- fold
increase of extent index and 1.73- and 2.68- fold increase of
CCSS compared with high tertile of HDL-associated PON1
(57.85w154.82U/mL) and PON3 activities (39.63w124.10 U/mL),
respectively (all P < 0.01).
CONCLUSIONS Elevated apoA-I glycation and decreased activities of
HDL-associated PON1 and PON3, and their interaction are associated
with the presence and severity of CAD in patients with T2DM.
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OBJECTIVES To investigate the status of blood lipid in patients with
AMI over the last ten years in Beijing, and to analyze their baseline
condition and variation tendency. These will contribute to take the
targeted prevention strategies and speciﬁc measures for lipid control.
METHODS This was a retrospective study, which enrolled 339 in-
patients with acute myocardial infarction (AMI) in two hospitals be-
tween 2001-2003 and 2011-2014. All lipid parameters were measured
according to uniﬁed standard.
RESULTS There were 125 cases with AMI in 2011-2014, mean ages
62.4612.36 years old, and 214 cases in 2011-2014, mean
ages61.9913.30 years old. The levels of blood LDL-C in patients with
AMI in 2011-2014 were signiﬁcantly higher than that of lipid in 2001-
2003 (2.710.73 vs 3.070.82, p <0.01), the rate of hyper-
triglyceridemia and hypercholesterolemia was greater in patients in
2011-2014 (8.9% vs 17.0%, p <0.05;4.2% vs 10.2%, P¼0.059), too.
However, both the level of HDL-C and the rate of patients with low
HDL-C content grew worse in 2011-21014(1.080.27 vs 1.020.22,
p <0.05; 38.3% vs 54.9%, p <0.01). The level of LDL-C and TG in male
cases has kept on rising for ten years (1.350.63 vs 1.651.17, P <0.05;
2.670.71 vs 3.080.80, p <0.01), that of TG decreased steeply
(1.070.24 vs 1.010.22, P <0.05), but these remained unchanged for
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and 54 increased signiﬁcantly (4.550.86 vs 5.020.80; 2.580.69 vs
3.290.75, P<0.05), the same with the level of LDL-C in patients aged
between 55 and 64 (2.730.63 vs 3.210.89, P <0.05).
CONCLUSIONS Dyslipidemia has remained further deterioration, and
taken on atherogenic lipid proﬁle, it is especially obviously for male or
middle-aged patients with AMI. Powerful measures must be taken to
control dyslipidemia, targeted strategy should focuses on these pop-
ulation.GW26-e0710
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OBJECTIVES To evaluate the association between very low density
lipoprotein cholesterol (VLDL-C) and cholesterol absorption and
synthesis markers, for the exploration of the effective therapy to
reduce VLDL-C levels.
METHODS Total 363 statin-naïve patients with high risk of coronary
heart disease were recruited consecutively from two hospitals in
Shanxi and Henan provinces between October 2008 and June 2009. A
standard questionnaire and physical examination were conducted at
baseline. Atorvastatin was administered to patients at a dose of 20 mg
per day for 4 weeks. Venous blood samples after an overnight fast
were collected before and after treatment for laboratory measure-
ments, including VLDL-C and cholesterol absorption and synthesis
markers.
RESULTS (1) Of 363 patients, 318 were followed through this study,
and among them, 283 patients with mean age of 55.439.01 years
old were remained ﬁnally after excluding patients who were lost to
follow-up or with incomplete information. The median level of
baseline VLDL-C was 1.06 (0.65, 1.86) mmol/L. The median level of
baseline cholesterol absorption marker (Campesterol) and choles-
terol synthesis marker (Lathosterol) was 0.60 (0.78,0.94) mg/dl and
1.35 (0.83,2.11) mg/dl, respectively. (2) Partial correlation analysis
and multiple regression showed the baseline level of VLDL-C was
positively correlated with Campesterol (r¼0.153,b¼0.367, P<0.05)
but not with Lathosterol. Furthermore, in different cholesterol ab-
sorption and synthesis patterns, baseline VLDL-C level signiﬁcantly
increased with tertile of the baseline level of Campesterol in the
qualitative analysis. (3) A mean reduction in VLDL-C levels was
37.97% after 4 weeks atorvastatin treatment. The reduction of
VLDL-C level was positively correlated with the reduction in Cam-
pesterol (r¼0.331, P<0.001). And in the qualitative analyses, the
reduction in VLDL-C levels signiﬁcantly increased with the tertile of
Campesterol reduction (P for trend¼0.032). But this trend was not
observed for the association between the changes of VLDL-C level
and Lathosterol.
CONCLUSIONS The level of VLDL-C was closely related to cholesterol
absorption marker, and further studies are needed to validate the
hypothesis that whether the inhibitor of cholesterol absorption (Eze-
timibe) could bring about more effective VLDL-C lowering.GW26-e2268
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OBJECTIVES Familial hypercholesterolemia (FH) is a common and
serious dominant genetic disease, which characteristic by tendon
xanthoma, severely elevated LDL cholesterol (LDL-C) and premature
coronary heart disease. The main pathogenic gene is low density li-
poprotein receptor (LDLR) gene, which can explain 75% FH patients.
However, less data were reported in China. This study aim to system
review the LDLR mutations in China.
METHODS With a computerized literature index of Pubmed,
Embase, Wangfang (Chinese) and Chinese National Knowledge
Infrastructure (CNKI, Chinese), Chinese Biological and Medicaldatabase (CBM, Chinese), the public date were limited to December
2014. The Medical Subject Headings terms and following key words
were used: “familial hypercholesterolemia”, “Chinese”, “China”,
“Hong Kong”, “Taiwan”. Studies only included LDLR mutations
were included.
RESULTS A total of 59 studies were included in our review. There
are 340 probands included 129 LDLR mutations were reported. The
distribution of mutations showed most mutations were located in
exon 4 andbout 60% (77/129) mutations were missense mutations.
In addition, we found 28 novel mutations which were not recorded
in the LDLR databases. In silico analysis, most of mutations were
pathogenic, except two variants were identiﬁed as non-pathogenic:
N494S (c.1544A>G, p. Asn515Ser) and S533L (c.1661C>T, p. Ser554-
Leu). In addition, the three main mutations in China were C308Y
(c.986G>A, p.Cys329Tyr), H562Y (c.1747C>T, p.His583Tyr), and
A606T (c.1879G>A, p.Ala627Thr) and all of them had functional
analysis.
CONCLUSIONS The prevalence of heterozygous FH is found in
approximately 1/200 - 1/500, there are nearly 6 million patients in
China. This system review collect LDLR mutations in China, may
provide Chinese information to the international FH database.
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OBJECTIVES To study correlation between cholesterol synthesis with
absorption and reactivity to statin of high-risk coronary heart disease
(CHD) people with different cholesterol synthesis and absorption
degrees.
METHODS 159 subjects with high-risk CHD were enrolled, and 20mg
atorvastatin per day were taken for four weeks. Blood lipids and
markers of cholesterol synthesis and absorption were determined
respectively before and after treatment. Squalene/TC (Squalenea) and
Sitoserlo/TC (Squalenea) were analyzed, which represents the levels
of cholesterol synthesis and absorption, respectively.
RESULTS ① In the low-absorption group, the high synthesis people
accounted for 41%, the low for 12.8%; In the high absorption
group, the high synthesis people only accounted for 7.5%, the low
is as high as 35%, with signiﬁcantly difference (p ¼ 0.001). With the
increase of synthesis, the number of subjects with high absorption
decreases. Accordingly, with the increase of absorption, the number
of subjects with high synthesis decreases as well, trend test p ¼
0.0001. ②; After statin treatment, no subject with synthesis greatly
reduced in low synthesis group, but as high as 75% in high syn-
thesis group, statistical difference signiﬁcant (p ¼ 0.000). With the
increase of synthesis, the number of synthesis reduced increases,
trend test p ¼ 0.000. ③After treatment, the synthesis reduction is
51.3% in low absorption group, but only 22.5% in high absorption
group, with signiﬁcantly difference (p ¼ 0.035). With increasing of
absorption, the number of synthesis reduced decreases, trend test
p ¼ 0.033.
CONCLUSIONS The negative feedback regulation mechanism be-
tween cholesterol synthesis and absorption exists in the Chinese high-
risk CHD population. The higher cholesterol synthesis degree in
baseline, the better reactivity to statin, but it shows the opposite
tendency for cholesterol absorption.GW26-e2276
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OBJECTIVES To explore the relationship between fasting serum level
of b2-microglobulin (b2-M) and arteriosclerosis in primary aldoste-
ronism (PA).
